Can you beat the market with AstraZeneca plc, BAE Systems plc and ARM Holdings plc?

AstraZeneca plc (LON: AZN), BAE Systems plc (LON: BA) and Arm holdings plc (LON: ARM) could help turobocharge your portfolio’s returns.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Trying to build an equity portfolio from scratch is a daunting process. Where do you start? Well, there are three main ‘buckets’ of equities you can use to construct an all-weather portfolio that will generate steady returns over time. These three buckets are income, growth, and growth & income.

If you start at the beginning and buy one stock that falls into each one of these buckets, it’s difficult to go wrong, and you’ll have a solid portfolio backbone from which you can build out other equity positions. Here are three stocks that could be the perfect candidates.

Top income pick

When it comes to income, AstraZeneca (LSE: AZN) is a top pick. The drugs giant operates in a defensive industry and has always prioritised cash returns to investors. Indeed, dividends are so important to the company that Astra’s management compensation is linked to the company’s dividend payout. In other words, if shareholders don’t receive a set proportion of Astra’s income, then the company’s management has to take a pay cut.

For the past five years Astra’s shares have supported an average dividend yield of 4.9% and at present prices, the yield stands at 4.8%. The dividend payout is covered 1.5 times by earnings per share and Astra’s shares trade at a relatively attractive forward P/E of 14.6.

Rapid growth

BAE Systems (LSE: BA) provides the perfect blend of both growth and income. City analysts have pencilled-in a pre-tax profit of £1.5bn for 2016, and if BAE hits this target, the company will have seen its pre-tax profit grow by 270% over just four years. On a per share basis, analysts are expecting BAE to report earnings of 38.5p for the year ending 31 December 2016.

On this basis, the defence group’s shares trade at a forward P/E of 12.3. Analysts are currently expecting earnings per share growth of 7% for the year ending 31 December 2017.

What’s more, over the years BAE has built a reputation as an income champion. During the past five years the company’s shares have supported an average dividend yield of 5.1% and at current prices shares in BAE yield 4.3%. The payout is covered 1.9 times by earnings per share.

Unique growth

Astra and BAE both offer growth and income, but when it comes to a pure growth play, you can’t go wrong with Arm (LSE: ARM).

Despite concerns about the state of the semiconductor industry and flagging smartphone sales, at the end of April Arm reported a robust set of first-quarter numbers allaying worries about the company’s ability to grow in a maturing market. Revenues of $398m were up 14% year-on-year and 22% ahead in sterling terms, while pre-tax profits expanded 14% to $137.5m and earnings per share rose 15% to 8.2p, despite the fact that operating costs increased by a third. 

City analysts expect Arm’s earnings per share to grow by 43% to 34.6p overall this year, which puts the group on a forward P/E of 28.2 — its lowest valuation in five years. Arm’s shares only offer a token dividend yield of 1%.

Rupert Hargreaves has no position in any shares mentioned. The Motley Fool UK has recommended ARM Holdings and AstraZeneca. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Young mixed-race woman jumping for joy in a park with confetti falling around her
Investing Articles

I asked ChatGPT for the best FTSE 100 stock for total returns in 2026, and guess what it said…

Are AI chatbots any better than humans at digging out the best value FTSE 100 stocks to consider buying? They…

Read more »

UK money in a Jar on a background
Investing Articles

How much should someone invest to target a £100 weekly second income?

Bringing in a second income can spell the difference between comfort or crisis when an emergency happens. Mark Hartley breaks…

Read more »

Emma Raducanu for Vodafone billboard animation at Piccadilly Circus, London
Investing Articles

Is now the time to consider buying Vodafone shares?

Vodafone shares have been on a roll, transforming a £5,000 investment 12 months ago into £8,455 today. But is the…

Read more »

Female Tesco employee holding produce crate
Investing Articles

Is now the time to consider buying Tesco shares?

Tesco shares have been a stellar performer over the last 12 months, but can this momentum continue? Or is it…

Read more »

Finger clicking a button marked 'Buy' on a keyboard
Investing Articles

Is this the perfect time to consider buying Legal & General shares?

Legal & General shares have one of the FTSE 100's biggest forecast dividend yields for 2026. Maybe we should think…

Read more »

Passive income text with pin graph chart on business table
Investing Articles

These are the FTSE 100’s 5 biggest passive-income streams!

These five FTSE 100 firms are expected to pay out £30.5bn in cash dividends in 2026. I'm a huge fan…

Read more »

Investing Articles

Up 50% in a year! Now check out the intriguing BP share price forecast for the next 12 months

The BP share price is up one day, down the next, as geopolitical uncertainty rattles the FTSE 100. Harvey Jones…

Read more »

Investing Articles

Is now the perfect time to buy high-yield FTSE 100 dividend shares? 

Harvey Jones says UK dividend shares have a brilliant track record of delivering income and growth, and he can see…

Read more »